TY - JOUR
T1 - Excess Body Fatness during Early to Mid-Adulthood and Survival from Colorectal and Breast Cancer
T2 - A Pooled Analysis of Five International Cohort Studies
AU - Charvat, Hadrien
AU - Freisling, Heinz
AU - Noh, Hwayoung
AU - Gaudet, Mia M.
AU - Gunter, Marc J.
AU - Cross, Amanda J.
AU - Tsilidis, Konstantinos K.
AU - Tjønneland, Anne
AU - Katzke, Verena
AU - Bergmann, Manuela
AU - Agnoli, Claudia
AU - Rylander, Charlotta
AU - Skeie, Guri
AU - Jakszyn, Paula
AU - Rosendahl, Ann H.
AU - Sund, Malin
AU - Severi, Gianluca
AU - Tsugane, Shoichiro
AU - Sawada, Norie
AU - Brenner, Hermann
AU - Adami, Hans Olov
AU - Weiderpass, Elisabete
AU - Soerjomataram, Isabelle
AU - Arnold, Melina
N1 - Publisher Copyright:
©2021 American Association for Cancer Research
PY - 2022/2/1
Y1 - 2022/2/1
N2 - Background: Here, we explore the association between excess weight during early to mid-adulthood and survival in patients diagnosed with breast and colorectal cancer, using a pooled analysis of five cohort studies and study participants from 11 countries. Methods: Participant-level body mass index (BMI) trajectories were estimated by fitting a growth curve model using over 2 million repeated BMI measurements from close to 600,000 cohort participants. Cumulative measures of excess weight were derived. Data from over 23,000 patients with breast and colorectal cancer were subsequently analyzed using time-to-event models for death with the date of diagnosis as start of follow-up. Study-specific results were combined through a random effect meta-analysis. Results: We found a significant dose–response relationship (P trend ¼ 0.013) between the average BMI during early and mid-adulthood and death from breast cancer, with a pooled HR of 1.31 (1.07–1.60) and the time to death shortened by 16% for average BMI above 25 kg/m2 compared with average BMI less than or equal to 22.5 kg/m2, respectively. Similar results were found for categories of cumulative time spent with excess weight. There was no association between excess body fatness during early to mid-adulthood and death in patients with colorectal cancer. Conclusions: Excess body fatness during early to mid-adulthood is associated not only with an increased risk of developing cancer, but also with a lower survival in patients with breast cancer.
AB - Background: Here, we explore the association between excess weight during early to mid-adulthood and survival in patients diagnosed with breast and colorectal cancer, using a pooled analysis of five cohort studies and study participants from 11 countries. Methods: Participant-level body mass index (BMI) trajectories were estimated by fitting a growth curve model using over 2 million repeated BMI measurements from close to 600,000 cohort participants. Cumulative measures of excess weight were derived. Data from over 23,000 patients with breast and colorectal cancer were subsequently analyzed using time-to-event models for death with the date of diagnosis as start of follow-up. Study-specific results were combined through a random effect meta-analysis. Results: We found a significant dose–response relationship (P trend ¼ 0.013) between the average BMI during early and mid-adulthood and death from breast cancer, with a pooled HR of 1.31 (1.07–1.60) and the time to death shortened by 16% for average BMI above 25 kg/m2 compared with average BMI less than or equal to 22.5 kg/m2, respectively. Similar results were found for categories of cumulative time spent with excess weight. There was no association between excess body fatness during early to mid-adulthood and death in patients with colorectal cancer. Conclusions: Excess body fatness during early to mid-adulthood is associated not only with an increased risk of developing cancer, but also with a lower survival in patients with breast cancer.
UR - http://www.scopus.com/inward/record.url?scp=85124180072&partnerID=8YFLogxK
U2 - 10.1158/1055-9965.EPI-21-0688
DO - 10.1158/1055-9965.EPI-21-0688
M3 - Article
C2 - 34782393
AN - SCOPUS:85124180072
SN - 1055-9965
VL - 31
SP - 325
EP - 333
JO - Cancer Epidemiology Biomarkers and Prevention
JF - Cancer Epidemiology Biomarkers and Prevention
IS - 2
ER -